YEAR
- 2007.02.20 Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Yanai H, Chen HM, Inuzuka T, Kondo S, Mak TW, Takaoka A, Honda K, Taniguchi T.Proc. Natl. Acad. Sci. U.S.A. 2007 Feb 27;104(9):3402-7. doi: 10.1073/pnas.0611559104
- 2007.10.20 Pitx2 prevents osteoblastic transdifferentiation of myoblasts by bone morphogenetic proteins. Hayashi M, Maeda S, Aburatani H, Kitamura K, Miyoshi H, Miyazono K, Imamura T.J. Biol. Chem. 2008 Jan 04;283(1):565-71. doi: 10.1074/jbc.M708154200
- 2007.07.17 Personalized medicine and proteomics: lessons from non-small cell lung cancer. Marko-Varga G, Ogiwara A, Nishimura T, Kawamura T, Fujii K, Kawakami T, Kyono Y, Tu HK, Anyoji H, Kanazawa M, Akimoto S, Hirano T, Tsuboi M, Nishio K, Hada S, Jiang H, Fukuoka M, Nakata K, Nishiwaki Y, Kunito H, Peers IS, Harbron CG, South MC, Higenbottam T, Nyberg F, Kudoh S, Kato H.J. Proteome Res. 2007 Aug;6(8):2925-35. doi: 10.1021/pr070046s
- 2007.06.25 Pathological role of osteoclast costimulation in arthritis-induced bone loss. Ochi S, Shinohara M, Sato K, Gober HJ, Koga T, Kodama T, Takai T, Miyasaka N, Takayanagi H.Proc. Natl. Acad. Sci. U.S.A. 2007 Jul 03;104(27):11394-9. doi: 10.1073/pnas.0701971104
- 2007.04.20 Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination. Lim MK, Kawamura T, Ohsawa Y, Ohtsubo M, Asakawa S, Takayanagi A, Shimizu N.Exp. Cell Res. 2007 Aug 01;313(13):2858-74. doi: 10.1016/j.yexcr.2007.04.016
- 2007.04.10 p63 - Key molecule in the early phase of epithelial abnormality in idiopathic pulmonary fibrosis. Murata K, Ota S, Niki T, Goto A, Li CP, Ruriko UM, Ishikawa S, Aburatani H, Kuriyama T, Fukayama M.Exp. Mol. Pathol. 2007 Dec;83(3):367-76. doi: 10.1016/j.yexmp.2007.03.006
- 2007.12.31 Overexpression of SOX15 inhibits proliferation of NT2/D1 cells derived from a testicular embryonal cell carcinoma. Yan HT, Shinka T, Sato Y, Yang XJ, Chen G, Sakamoto K, Kinoshita K, Aburatani H, Nakahori Y.Mol. Cells. 2007 Dec 31;24(3):323-8.
- 2007.04.03 New therapeutic target for metabolic syndrome: PPARdelta. Takahashi S, Tanaka T, Sakai J.Endocr. J. 2007 Jun;54(3):347-57. doi: 10.1507/endocrj.kr-99
CLOSE